Dr. Brad Vince of Vince & Associates Clinical Research Announces Award of Nearly $10 Million Contract from the National Institute on Drug Abuse

September 18, 2012

Company News Release

Vince & Associates Clinical Research

announced it has been awarded a contract with the

National Institute on Drug Abuse

, part of the

National Institutes of Health (NIH)

, to carry out clinical pharmacology studies to determine the pharmacokinetics and pharmacodynamics of new medication in humans.

This award is a five year contract with a ceiling value of $9,695,476 beginning September 2012. Vince and Associates will conduct clinical pharmacology studies to support the development of new medications for the treatment of substance abuse disorders.

“Our organization will research investigational medications to include new chemical entities, new biological products such as monoclonal antibodies, enzymes and vaccines as well as already approved drug products,” said

Dr. Brad Vince

, president and medical director of Vince & Associates Clinical Research. “Our organization is excited to work on clinical studies with NIDA that may benefit those struggling with substance abuse disorders.”

Related Content:

News